Phase 3 N=166 Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis
Multiple Sclerosis
Primary: Time to First Confirmed Clinical Relapse — 39.14; 75.29 weeks — p=0.2949
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=282 Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease
Pulmonary Disease, Chronic Obstructive
Primary: Change From Baseline in FEV1 to Day 7 - ITT Population — 0.084; 0.115; 0.057 litre — p=0.012
N/A N=12 Electrical Stimulation of the Muscle Pumps of the Leg
Haemodynamic Physiology
Primary: Venous Haemodynamic Measurements (Volume Flow Rate) — 119; 158; 158; 144 ml/min — p=<0.05
Phase 2 N=8 QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML
Acute Myeloid Leukemia
Primary: Number of Participants With Complete Remission With or Without Incomplete Platelet Recovery — 1 Participants
Phase 3 N=490 This Trial is a Randomised, Multicentre, Investigator-blind, Vehicle and Comparator-controlled, Parallel-group Trial With the Purpose of Evaluation Efficacy, Safety and Convenience of the MC2-01 Cream
Psoriasis Vulgaris
Primary: Percentage Change in mPASI (Modified Psoriasis Area and Severity Index) Score — -67.5; -63.5; -11.7 Percentage change from Baseline
Phase 2 N=15 Tarceva And Radiotherapy in Locally Advanced Lung Cancer Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Primary: Progression Free Survival — 9.4 months
N/A N=166 Effects of Oxytocin on Bleeding Outcomes During Dilation and Evacuation
Abortion · Dilation and Evacuation · Hemorrhage
Primary: Rate at Which Providers Intervene to Control Blood Loss During D&E Procedures. — 13; 6 Participants
Phase 4 N=36 Drug Concentration Analysis of Micafungin in Overweight, Obese, and Extremely Obese Volunteers
Obesity · Nutrition Disorders · Overweight
Primary: Serum Clearance of Micafungin
N/A N=46 eCoin Tibial Nerve Stimulation for OAB
Urgency Urinary Incontinence
Primary: Incontinent Episodes — -3.0 episodes/day
N/A N=60 Study of Reminding to Improve Medication Adherence in Heart Failure
Heart Failure
Primary: Patient Acceptance — 33.4; 33.4; 48.7; 48.7 units on a scale
N/A N=20 Evaluation of the Safety and Efficacy of the Pico Laser With a Specialized Lens Array for the Treatment of Wrinkles
Wrinkles
Primary: Photographic Evaluation of Wrinkle Severity at Baseline — 5.7 score on a scale
N/A N=11 Effect of Alternate Therapies on Intraocular Pressure in Ocular Hypertension
Ocular Hypertension
Primary: Change From Baseline in Intraocular Pressure (mmHg) — 25.3; 26.8; 23.9; 22.5 mm Hg
Phase 4 N=149 RHYTHM (Formerly Escape II Myocardium)
Rheumatoid Arthritis
Primary: Number of Participants With Myocardial FDG Uptake — 21; 4; 25; 1 Participants
Phase 2 N=48 Comparison of a Pain Pump Versus Injectable Medication for Analgesia in Knee Arthroscopy
Pain
Primary: Pain Score 8 Hours Post-operativley — 2.5; 1.8; 1.06 units on a scale
Phase 2 N=124 A Study of Safety and Efficacy of UNR844 Chloride (UNR844-Cl) Eye Drops in Subjects With Presbyopia.
Presbyopia
Primary: Change in Binocular Distance-corrected Near Visual Acuity (DCNVA) From Baseline — 6.1; 4.5 number of letters read correctly — p=0.1832